[BREAKING] MediPharm Labs SUES HEXO; Aphria & IIPR Raise Cash — and More! [Cannabis StockCast #43]

Cannabis extractor MediPharm Labs (Toronto: LABS) is suing Hexo Corp. (NYSE: HEXO) for roughly C$10 million in missed payments! But I don’t think the markets have priced in what this means for HEXO’s future.Lawsuits aside, Aphria Inc. (NYSE: APHA) and Innovative Industrial Properties Inc. (NYSE: IIPR) both raised cash through stock offerings. I explain why this is a great sign in the current market.And finally, Evolve Funds is shuttering three of its marijuana-based ETFs due to a lack of interest. Watch to find out why I think this is a great contrarian signal. Access my top 5 pot stock picks in the Alpha Investor Report! Click here to learn more: https://pro.banyanhill.com/m/1465136 About Me: I joined Banyan Hill in 2017 as a research analyst. A market “outsider,” I use my science background to create an objective view of investments. This approach allows me to overcome the emotional biases that plague the average investor. My background in biogeography taught me to analyze giant data sets for specific patterns. That translates perfectly to financial research, and I now apply those tools to find opportunities to profit in natural resources. Follow me on Social Media! Twitter: https://twitter.com/ThePotStockGuru Facebook: https://www.facebook.com/ThePotStockGuru/ Instagram: https://www.instagram.com/thepotstockguru/ Like the info in this video? Comment below and let me know! I’d love to receive suggestions for new video topics, so feel free to share what you’d like to hear in future videos!